Filing Details

Accession Number:
0001209191-16-114135
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-13 18:17:26
Reporting Period:
2016-04-13
Filing Date:
2016-04-13
Accepted Time:
2016-04-13 18:17:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1607678 Viking Therapeutics Inc. VKTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237556 W Matthew Foehr C/O Viking Therapeutics, Inc.
12340 El Camino Real, Suite 250
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.00001 Acquisiton 2016-04-13 20,000 $1.24 26,250 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to Buy) Acquisiton 2016-04-13 20,000 $0.01 20,000 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2016-04-13 2021-04-13 No 4 P Direct